The Epstein-Barr virus oncoprotein LMP1 inhibits the activity of viral or cellular promoters without inducing cytostasis

Virology

Volumn 350, Issue 2, 2006, Pages 381-393

  Narbonnet, Stéphane ^a   Mariamé, Bernard ^a  

^a CHU PURPAN   (France)

Author keywords

Cytostasis; EBV; LMP1; Membrane spanning domains; Promoters

Indexed keywords

LATENT MEMBRANE PROTEIN 1; ONCOPROTEIN;

APOPTOSIS; ARTICLE; CYTOSTASIS; EPSTEIN BARR VIRUS; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DOMAIN; VIRUS;

ANTIGENS, VIRAL; BASE SEQUENCE; BURKITT LYMPHOMA; CELL DIVISION; CELL LINE, TUMOR; DNA PRIMERS; EXONS; GENES, REPORTER; HERPESVIRUS 4, HUMAN; HUMANS; PROMOTER REGIONS (GENETICS); RESTRICTION MAPPING; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSCRIPTION FACTORS; VIRAL MATRIX PROTEINS;

HUMAN HERPESVIRUS 4;

EID: 33745240363     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2006.02.010     Document Type: Article

References (42)

1. Baichwal V.R., and Sugden B. Transformation of Balb 3T3 cells by the BNLF-1 gene of Epstein-Barr virus. Oncogene 2 5 (1988) 461-467
2. Ben-Bassat H., Goldblum N., Mitrani S., Goldblum T., Yoffey J.M., Cohen M.M., Bentwich Z., Ramot B., Klein E., and Klein G. Establishment in continuous culture of a new type of lymphocyte from a "Burkitt like" malignant lymphoma (line D.G.-75). Int. J. Cancer 19 1 (1977) 27-33
3. Chen H., Hutt-Fletcher L., Cao L., and Hayward S.D. A positive autoregulatory loop of LMP1 expression and STAT activation in epithelial cells latently infected with Epstein-Barr virus. J. Virol. 77 7 (2003) 4139-4148
4. Coffin III W.F., Erickson K.D., Hoedt-Miller M., and Martin J.M. The cytoplasmic amino-terminus of the Latent Membrane Protein-1 of Epstein-Barr Virus: relationship between transmembrane orientation and effector functions of the carboxy-terminus and transmembrane domain. Oncogene 20 38 (2001) 5313-5330
5. Coffin III W.F., Geiger T.R., and Martin J.M. Transmembrane domains 1 and 2 of the latent membrane protein 1 of Epstein-Barr virus contain a lipid raft targeting signal and play a critical role in cytostasis. J. Virol. 77 6 (2003) 3749-3758
6. Eliopoulos A.G., and Rickinson A.B. Epstein-Barr virus: LMP1 masquerades as an active receptor. Curr. Biol. 8 6 (1998) R196-R198
7. Eliopoulos A.G., and Young L.S. LMP1 structure and signal transduction. Semin. Cancer Biol. 11 6 (2001) 435-444
8. Eliopoulos A.G., Gallagher N.J., Blake S.M., Dawson C.W., and Young L.S. Activation of the p38 mitogen-activated protein kinase pathway by Epstein-Barr virus-encoded latent membrane protein 1 coregulates interleukin-6 and interleukin-8 production. J. Biol. Chem. 274 23 (1999) 16085-16096
9. Floettmann J.E., Ward K., Rickinson A.B., and Rowe M. Cytostatic effect of Epstein-Barr virus latent membrane protein-1 analyzed using tetracycline-regulated expression in B cell lines. Virology 223 1 (1996) 29-40
10. Gires O., Zimber-Strobl U., Gonnella R., Ueffing M., Marschall G., Zeidler R., Pich D., and Hammerschmidt W. Latent membrane protein 1 of Epstein-Barr virus mimics a constitutively active receptor molecule. EMBO J. 16 20 (1997) 6131-6140
11. Gires O., Kohlhuber F., Kilger E., Baumann M., Kieser A., Kaiser C., Zeidler R., Scheffer B., Ueffing M., and Hammerschmidt W. Latent membrane protein 1 of Epstein-Barr virus interacts with JAK3 and activates STAT proteins. EMBO J. 18 11 (1999) 3064-3073
12. Hammarskjold M.L., and Simurda M.C. Epstein-Barr virus latent membrane protein transactivates the human immunodeficiency virus type 1 long terminal repeat through induction of NF-kappa B activity. J. Virol. 66 11 (1992) 6496-6501
13. Hammerschmidt W., Sugden B., and Baichwal V.R. The transforming domain alone of the latent membrane protein of Epstein-Barr virus is toxic to cells when expressed at high levels. J. Virol. 63 6 (1989) 2469-2475
14. Henderson S., Rowe M., Gregory C., Croom-Carter D., Wang F., Longnecker R., Kieff E., and Rickinson A. Induction of bcl-2 expression by Epstein-Barr virus latent membrane protein 1 protects infected B cells from programmed cell death. Cell 65 7 (1991) 1107-1115
15. Higuchi M., Izumi K.M., and Kieff E. Epstein-Barr virus latent-infection membrane proteins are palmitoylated and raft-associated: protein 1 binds to the cytoskeleton through TNF receptor cytoplasmic factors. Proc. Natl. Acad. Sci. U.S.A. 98 8 (2001) 4675-4680
16. Horvai A.E., Xu L., Korzus E., Brard G., Kalafus D., Mullen T.M., Rose D.W., Rosenfeld M.G., and Glass C.K. Nuclear integration of JAK/STAT and Ras/AP-1 signaling by CBP and p300. Proc. Natl. Acad. Sci. U.S.A. 94 4 (1997) 1074-1079
17. Kaye K.M., Izumi K.M., and Kieff E. Epstein-Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation. Proc. Natl. Acad. Sci. U.S.A. 90 19 (1993) 9150-9154
18. Kaykas A., and Sugden B. The amino-terminus and membrane-spanning domains of LMP-1 inhibit cell proliferation. Oncogene 19 11 (2000) 1400-1410
19. Kieff E., and Rickinson A. Epstein-Barr virus and its replication. In: Knipe D., Howley P., Griffin D., et al. (Eds). Fields Virol. vol. 2 (2001), Lippincott Williams Wilkins, Philadelphia 2511-2573
20. Kieser A., Kilger E., Gires O., Ueffing M., Kolch W., and Hammerschmidt W. Epstein-Barr virus latent membrane protein-1 triggers AP-1 activity via the c-Jun N-terminal kinase cascade. EMBO J. 16 21 (1997) 6478-6485
21. Kilger E., Kieser A., Baumann M., and Hammerschmidt W. Epstein-Barr virus-mediated B-cell proliferation is dependent upon latent membrane protein 1, which simulates an activated CD40 receptor. EMBO J. 17 6 (1998) 1700-1709
22. Kulwichit W., Edwards R.H., Davenport E.M., Baskar J.F., Godfrey V., and Raab-Traub N. Expression of the Epstein-Barr virus latent membrane protein 1 induces B cell lymphoma in transgenic mice. Proc. Natl. Acad. Sci. U.S.A. 95 20 (1998) 11963-11968
23. Laherty C.D., Hu H.M., Opipari A.W., Wang F., and Dixit V.M. The Epstein-Barr virus LMP1 gene product induces A20 zinc finger protein expression by activating nuclear factor kappa B. J. Biol. Chem. 267 34 (1992) 24157-24160
24. Lam N., and Sugden B. CD40 and its viral mimic, LMP1: similar means to different ends. Cell Signal 15 1 (2003) 9-16
25. Lam N., Sandberg M.L., and Sugden B. High physiological levels of LMP1 result in phosphorylation of eIF2 alpha in Epstein-Barr virus-infected cells. J. Virol. 78 4 (2004) 1657-1664
26. Lee Y., Sohn W.J., Kim D.S., and Kwon H.J. NF-kappaB- and c-Jun-dependent regulation of human cytomegalovirus immediate-early gene enhancer/promoter in response to lipopolysaccharide and bacterial CpG-oligodeoxynucleotides in macrophage cell line RAW 264.7. Eur. J. Biochem. 271 6 (2004) 1094-1105
27. Miller W.E., Earp H.S., and Raab-Traub N. The Epstein-Barr virus latent membrane protein 1 induces expression of the epidermal growth factor receptor. J. Virol. 69 7 (1995) 4390-4398
28. Mizushima S., and Nagata S. pEF-BOS, a powerful mammalian expression vector. Nucleic Acids Res. 18 17 (1990) 5322
29. Murono S., Inoue H., Tanabe T., Joab I., Yoshizaki T., Furukawa M., and Pagano J.S. Induction of cyclooxygenase-2 by Epstein-Barr virus latent membrane protein 1 is involved in vascular endothelial growth factor production in nasopharyngeal carcinoma cells. Proc. Natl. Acad. Sci. U.S.A. 98 12 (2001) 6905-6910
30. Patel T., Gores G.J., and Kaufmann S.H. The role of proteases during apoptosis. FASEB J. 10 5 (1996) 587-597
31. Puls A., Eliopoulos A.G., Nobes C.D., Bridges T., Young L.S., and Hall A. Activation of the small GTPase Cdc42 by the inflammatory cytokines TNF (alpha) and IL-1, and by the Epstein-Barr virus transforming protein LMP1. J. Cell Sci. 112 Pt. 17 (1999) 2983-2992
32. Sandberg M.L., Kaykas A., and Sugden B. Latent membrane protein 1 of Epstein-Barr virus inhibits as well as stimulates gene expression. J. Virol. 74 20 (2000) 9755-9761
33. Sugimoto M., Tahara H., Ide T., and Furuichi Y. Steps involved in immortalization and tumorigenesis in human B-lymphoblastoid cell lines transformed by Epstein-Barr virus. Cancer Res. 64 10 (2004) 3361-3364
34. Tabakin-Fix Y., Huleihel M., and Aboud M. Activation of simian virus 40 promoter by HTLV-I Tax protein: role of NF-kappaB and CBP. Biochem. Biophys. Res. Commun. 318 4 (2004) 1052-1056
35. Takeshita H., Yoshizaki T., Miller W.E., Sato H., Furukawa M., Pagano J.S., and Raab-Traub N. Matrix metalloproteinase 9 expression is induced by Epstein-Barr virus latent membrane protein 1 C-terminal activation regions 1 and 2. J. Virol. 73 7 (1999) 5548-5555
36. Wakabayashi-Ito N., and Nagata S. Characterization of the regulatory elements in the promoter of the human elongation factor-1 alpha gene. J. Biol. Chem. 269 47 (1994) 29831-29837
37. Wang D., Liebowitz D., and Kieff E. An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells. Cell 43 3 Pt. 2 (1985) 831-840
38. Wang D., Liebowitz D., Wang F., Gregory C., Rickinson A., Larson R., Springer T., and Kieff E. Epstein-Barr virus latent infection membrane protein alters the human B-lymphocyte phenotype: deletion of the amino terminus abolishes activity. J. Virol. 62 11 (1988) 4173-4184
39. Wilson J.B., Weinberg W., Johnson R., Yuspa S., and Levine A.J. Expression of the BNLF-1 oncogene of Epstein-Barr virus in the skin of transgenic mice induces hyperplasia and aberrant expression of keratin 6. Cell 61 7 (1990) 1315-1327
40. Yasui T., Luftig M., Soni V., and Kieff E. Latent infection membrane protein transmembrane FWLY is critical for intermolecular interaction, raft localization, and signaling. Proc. Natl. Acad. Sci. U.S.A. 101 1 (2004) 278-283
41. Young L.S., and Rickinson A.B. Epstein-Barr virus: 40 years on. Nat. Rev., Cancer 4 10 (2004) 757-768
42. Zhang Q., Brooks L., Busson P., Wang F., Charron D., Kieff E., Rickinson A.B., and Tursz T. Epstein-Barr virus (EBV) latent membrane protein 1 increases HLA class II expression in an EBV-negative B cell line. Eur. J. Immunol. 24 6 (1994) 1467-1470